Skip to main content
PMC home page
Thorax logoLink to Thorax
. 1994 Jan;49(1):23–25. doi: 10.1136/thx.49.1.23

Efficacy of short term versus long term tube thoracostomy drainage before tetracycline pleurodesis in the treatment of malignant pleural effusions.

A G Villanueva 1, A W Gray Jr 1, D M Shahian 1, W A Williamson 1, J F Beamis Jr 1
PMCID: PMC474079  PMID: 7512285

Abstract

BACKGROUND--A study was undertaken to compare the efficacy of short term tube thoracostomy drainage with standard tube thoracostomy drainage before instillation of tetracycline for sclerotherapy of malignant pleural effusions. METHODS--The study consisted of a randomised clinical trial in a sequential sample of 25 patients with malignant pleural effusions documented cytopathologically. Fifteen patients were randomly assigned to group 1 (standard protocol) and 10 to group 2 (short term protocol). Patients in group 1 had tube thoracostomy suction drainage until radiological evidence of lung re-expansion was obtained and the amount of fluid drained was < 150 ml/day, before tetracycline (1.5 g) was instilled. The chest tube was removed when the amount of fluid drained after instillation was < 150 ml/day. Patients in group 2 also had suction drainage, but the tetracycline (1.5 g) was instilled when the chest radiograph showed the lung to be re-expanded and the effusion drained, which was usually within 24 hours. The chest tube was removed the next day. RESULTS--The response to tetracycline sclerotherapy in the two groups was the same (80%) but the duration of chest tube drainage was significantly shorter for patients in group 2 (median two days) than for those in group 1 (median seven days). CONCLUSIONS--The duration of chest tube drainage before sclerotherapy for malignant pleural effusions need not be influenced by the amount of fluid drained daily but by radiographic evidence of fluid evacuation and lung re-expansion. Shorter duration of drainage will reduce the length of hospital stay without sacrificing the efficacy of pleurodesis.

Full text

PDF
23

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adler R. H., Rappole B. W. Recurrent malignant pleural effusions and talc powder aerosol treatment. Surgery. 1967 Dec;62(6):1000–1006. [PubMed] [Google Scholar]
  2. Adler R. H., Sayek I. Treatment of malignant pleural effusion: a method using tube thoracostomy and talc. Ann Thorac Surg. 1976 Jul;22(1):8–15. doi: 10.1016/s0003-4975(10)63944-6. [DOI] [PubMed] [Google Scholar]
  3. Anderson C. B., Philpott G. W., Ferguson T. B. The treatment of malignant pleural effusions. Cancer. 1974 Apr;33(4):916–922. doi: 10.1002/1097-0142(197404)33:4<916::aid-cncr2820330405>3.0.co;2-u. [DOI] [PubMed] [Google Scholar]
  4. Bitran J. D., Brown C., Desser R. K., Kozloff M. F., Shapiro C., Billings A. A. Intracavitary bleomycin for the control of malignant effusions. J Surg Oncol. 1981;16(3):273–277. doi: 10.1002/jso.2930160312. [DOI] [PubMed] [Google Scholar]
  5. CAMISHION R. C., GIBBON J. H., Jr, NEALON T. F., Jr Talc poudrage in the treatment of pleural effusion due to cancer. Surg Clin North Am. 1962 Dec;42:1521–1526. doi: 10.1016/s0039-6109(16)36840-2. [DOI] [PubMed] [Google Scholar]
  6. Chernow B., Sahn S. A. Carcinomatous involvement of the pleura: an analysis of 96 patients. Am J Med. 1977 Nov;63(5):695–702. doi: 10.1016/0002-9343(77)90154-1. [DOI] [PubMed] [Google Scholar]
  7. Dollinger M. R., Krakoff I. H., Karnofsky D. A. Quinacrine (Atabrine) in the treatment of neoplastic effusions. Ann Intern Med. 1967 Feb;66(2):249–257. doi: 10.7326/0003-4819-66-2-249. [DOI] [PubMed] [Google Scholar]
  8. Fentiman I. S. Diagnosis and treatment of malignant pleural effusions. Cancer Treat Rev. 1987 Jun;14(2):107–118. doi: 10.1016/0305-7372(87)90043-0. [DOI] [PubMed] [Google Scholar]
  9. Fentiman I. S., Rubens R. D., Hayward J. L. A comparison of intracavitary talc and tetracycline for the control of pleural effusions secondary to breast cancer. Eur J Cancer Clin Oncol. 1986 Sep;22(9):1079–1081. doi: 10.1016/0277-5379(86)90009-x. [DOI] [PubMed] [Google Scholar]
  10. GELLHORN A., ZAIDENWEBER J., ULTMANN J., HIRSCHBERG E. The use of atabrine (quinacrine) in the control of recurrent neoplastic effusions. A preliminary report. Dis Chest. 1961 Feb;39:165–176. doi: 10.1378/chest.39.2.165. [DOI] [PubMed] [Google Scholar]
  11. Gravelyn T. R., Michelson M. K., Gross B. H., Sitrin R. G. Tetracycline pleurodesis for malignant pleural effusions. A 10-year retrospective study. Cancer. 1987 Jun 1;59(11):1973–1977. doi: 10.1002/1097-0142(19870601)59:11<1973::aid-cncr2820591124>3.0.co;2-2. [DOI] [PubMed] [Google Scholar]
  12. HAUPT G. J., CAMISHION R. C., TEMPLETON J. Y., GIBBON J. H., Jr Treatment of malignant pleural effusions by talc poudrage. J Am Med Assoc. 1960 Feb 27;172:918–921. doi: 10.1001/jama.1960.03020090030008. [DOI] [PubMed] [Google Scholar]
  13. Hausheer F. H., Yarbro J. W. Diagnosis and treatment of malignant pleural effusion. Semin Oncol. 1985 Mar;12(1):54–75. [PubMed] [Google Scholar]
  14. Hickman J. A., Jones M. C. Treatment of neoplastic pleural effusions with local instillations of quinacrine (mepacrine) hydrochloride. Thorax. 1970 Mar;25(2):226–229. doi: 10.1136/thx.25.2.226. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. JENSIK R., CAGLE J. E., Jr, MILLOY F., PERLIA C., TAYLOR S., KOFMAN S., BEATTIE E. J., Jr PLEURECTOMY IN THE TREATMENT OF PLEURAL EFFUSION DUE TO METASTATIC MALIGNANCY. J Thorac Cardiovasc Surg. 1963 Sep;46:322–330. [PubMed] [Google Scholar]
  16. Kefford R. F., Woods R. L., Fox R. M., Tatterall M. H. Intracavitary adriamycin nitrogen mustard and tetracycline in the control of malignant effusions: a randomized study. Med J Aust. 1980 Oct 18;2(8):447–448. doi: 10.5694/j.1326-5377.1980.tb131916.x. [DOI] [PubMed] [Google Scholar]
  17. Kessinger A., Wigton R. S. Intracavitary bleomycin and tetracycline in the management of malignant pleural effusions: a randomized study. J Surg Oncol. 1987 Oct;36(2):81–83. doi: 10.1002/jso.2930360202. [DOI] [PubMed] [Google Scholar]
  18. Lambert C. J., Shah H. H., Urshel H. C., Jr, Paulson D. L. The treatment of malignant pleural effusions by closed trocar tube drainage. Ann Thorac Surg. 1967 Jan;3(1):1–5. doi: 10.1016/s0003-4975(10)66681-7. [DOI] [PubMed] [Google Scholar]
  19. Leahy B. C., Honeybourne D., Brear S. G., Carroll K. B., Thatcher N., Stretton T. B. Treatment of malignant pleural effusions with intrapleural Corynebacterium parvum or tetracycline. Eur J Respir Dis. 1985 Jan;66(1):50–54. [PubMed] [Google Scholar]
  20. Lee Y. W., Gisser S. D. Squamous cell carcinoma of the tongue in a nine year renal transplant survivor: a case report with a discussion of the risk of development of epithelial carcinomas in renal transplant survivors. Cancer. 1978 Jan;41(1):1–6. doi: 10.1002/1097-0142(197801)41:1<1::aid-cncr2820410101>3.0.co;2-1. [DOI] [PubMed] [Google Scholar]
  21. Little A. G., Kadowaki M. H., Ferguson M. K., Staszek V. M., Skinner D. B. Pleuro-peritoneal shunting. Alternative therapy for pleural effusions. Ann Surg. 1988 Oct;208(4):443–450. doi: 10.1097/00000658-198810000-00006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Malden L. T., Tattersall M. H. Malignant effusions. Q J Med. 1986 Mar;58(227):221–239. [PubMed] [Google Scholar]
  23. Martini N., Bains M. S., Beattie E. J., Jr Indications for pleurectomy in malignant effusion. Cancer. 1975 Mar;35(3):734–738. doi: 10.1002/1097-0142(197503)35:3<734::aid-cncr2820350328>3.0.co;2-n. [DOI] [PubMed] [Google Scholar]
  24. McAlpine L. G., Hulks G., Thomson N. C. Management of recurrent malignant pleural effusion in the United Kingdom: survey of clinical practice. Thorax. 1990 Sep;45(9):699–701. doi: 10.1136/thx.45.9.699. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Ostrowski M. J. An assessment of the long-term results of controlling the reaccumulation of malignant effusions using intracavity bleomycin. Cancer. 1986 Feb 15;57(4):721–727. doi: 10.1002/1097-0142(19860215)57:4<721::aid-cncr2820570407>3.0.co;2-5. [DOI] [PubMed] [Google Scholar]
  26. Ostrowski M. J., Priestman T. J., Houston R. F., Martin W. M. A randomized trial of intracavitary bleomycin and Corynebacterium parvum in the control of malignant pleural effusions. Radiother Oncol. 1989 Jan;14(1):19–26. doi: 10.1016/0167-8140(89)90004-2. [DOI] [PubMed] [Google Scholar]
  27. Paladine W., Cunningham T. J., Sponzo R., Donavan M., Olson K., Horton J. Intracavitary bleomycin in the management of malignant effusions. Cancer. 1976 Nov;38(5):1903–1908. doi: 10.1002/1097-0142(197611)38:5<1903::aid-cncr2820380506>3.0.co;2-a. [DOI] [PubMed] [Google Scholar]
  28. Pearson F. G., MacGregor D. C. Talc poudrage for malignant pleural effusion. J Thorac Cardiovasc Surg. 1966 May;51(5):732–738. [PubMed] [Google Scholar]
  29. ROCHLIN D. B., SMART C. R., WAGNER D. E., SILVA A. R. THE CONTROL OF RECURRENT MALIGNANT EFFUSIONS USING QUINACRINE HYDROCHLORIDE. Surg Gynecol Obstet. 1964 May;118:991–994. [PubMed] [Google Scholar]
  30. Rubinson R. M., Bolooki H. Intrapleural tetracycline for control of malignant pleural effusion: a preliminary report. South Med J. 1972 Jul;65(7):847–849. doi: 10.1097/00007611-197207000-00016. [DOI] [PubMed] [Google Scholar]
  31. Ruckdeschel J. C., Moores D., Lee J. Y., Einhorn L. H., Mandelbaum I., Koeller J., Weiss G. R., Losada M., Keller J. H. Intrapleural therapy for malignant pleural effusions. A randomized comparison of bleomycin and tetracycline. Chest. 1991 Dec;100(6):1528–1535. doi: 10.1378/chest.100.6.1528. [DOI] [PubMed] [Google Scholar]
  32. STARKEY G. W. RECURRENT MALIGNANT PLEURAL EFFUSIONS. N Engl J Med. 1964 Feb 27;270:436–438. doi: 10.1056/NEJM196402272700902. [DOI] [PubMed] [Google Scholar]
  33. Sahn S. A. Pleural effusion in lung cancer. Clin Chest Med. 1982 May;3(2):443–452. [PubMed] [Google Scholar]
  34. Sarma P. R., Moore M. R. Approach to the management of pleural effusion in malignancy. South Med J. 1978 Feb;71(2):133–136. doi: 10.1097/00007611-197802000-00013. [DOI] [PubMed] [Google Scholar]
  35. Sherman S., Grady K. J., Seidman J. C. Clinical experience with tetracycline pleurodesis of malignant pleural effusions. South Med J. 1987 Jun;80(6):716–719. doi: 10.1097/00007611-198706000-00013. [DOI] [PubMed] [Google Scholar]
  36. Tattersall M. H., Boyer M. J. Management of malignant pleural effusions. Thorax. 1990 Feb;45(2):81–82. doi: 10.1136/thx.45.2.81. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Taylor S. A., Hooton N. S., Macarthur A. M. Quinacrine in the management of malignant pleural effusion. Br J Surg. 1977 Jan;64(1):52–53. doi: 10.1002/bjs.1800640113. [DOI] [PubMed] [Google Scholar]
  38. Tsang V., Fernando H. C., Goldstraw P. Pleuroperitoneal shunt for recurrent malignant pleural effusions. Thorax. 1990 May;45(5):369–372. doi: 10.1136/thx.45.5.369. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. ULTMANN J. E., GELLHORN A., OSNOS M., HIRSCHBERG E. The effect of quinacrine on neoplastic effusions and certain of their enzymes. Cancer. 1963 Mar;16:283–288. doi: 10.1002/1097-0142(196303)16:3<283::aid-cncr2820160303>3.0.co;2-j. [DOI] [PubMed] [Google Scholar]
  40. Wallach H. W. Intrapleural tetracycline for malignant pleural effusions. Chest. 1975 Oct;68(4):510–512. doi: 10.1378/chest.68.4.510. [DOI] [PubMed] [Google Scholar]
  41. Wallach H. W. Intrapleural therapy with tetracycline and lidocaine for malignant pleural effusions. Chest. 1978 Feb;73(2):246–246. doi: 10.1378/chest.73.2.246. [DOI] [PubMed] [Google Scholar]
  42. Walsh F. W., Alberts W. M., Solomon D. A., Goldman A. L. Malignant pleural effusions: pleurodesis using a small-bore percutaneous catheter. South Med J. 1989 Aug;82(8):963-5, 972. [PubMed] [Google Scholar]
  43. Zaloznik A. J., Oswald S. G., Langin M. Intrapleural tetracycline in malignant pleural effusions. A randomized study. Cancer. 1983 Feb 15;51(4):752–755. doi: 10.1002/1097-0142(19830215)51:4<752::aid-cncr2820510434>3.0.co;2-7. [DOI] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES